Breast Cancer in the Caribbean: What the Research Reveals About Our Region
Every October, we see the pink ribbons. We hear the reminders about mammograms, early detection and knowing our bodies. We listen to stories of survival, loss and hope.
But how often do we stop to ask what breast cancer actually looks like here in the Caribbean?
Not in the United States.
Not in Europe.
Here.
What do the numbers tell us about women in Trinidad and Tobago, Jamaica, Barbados, Guyana and the wider region? Are people being diagnosed early enough? Are they receiving treatment in time? And why do some communities appear to experience worse outcomes than others?
These questions matter because awareness is only one part of the breast cancer conversation.
A woman can recognise a suspicious lump and still struggle to obtain an appointment. She can undergo a mammogram and then face delays getting a biopsy. She can receive a diagnosis and discover that accessing the recommended treatment involves travelling long distances, taking time away from work or finding money her family does not have.
And even when medical services are officially available, that does not necessarily mean everyone can access them equally.
To understand breast cancer in the Caribbean, we need to look beyond individual responsibility and examine the healthcare systems, research gaps and social realities that influence what happens after someone notices something is wrong.
The evidence tells a complicated story.
It is a story of countries making progress, researchers uncovering important disparities and healthcare professionals working to improve outcomes. But it is also a story of lives that might be saved if diagnosis and treatment were more timely, accessible and consistent.
What Do the Numbers Actually Tell Us?
Before examining individual countries, we need to understand what cancer statistics measure.
Incidence refers to the number of new cases diagnosed within a particular period.
Mortality refers to deaths attributed to the disease.
Survival describes the proportion of people still alive after a specified period following diagnosis, often five years.
These measures are related, but they are not interchangeable.
A country can record a relatively high incidence of breast cancer because it has more cases, better detection or more complete cancer registration. Another country may record fewer diagnoses but experience substantial mortality because cancers are discovered later or treatment is difficult to access.
To compare populations fairly, researchers often use age-standardised rates, which account for differences in the age structures of populations. This is important because breast cancer risk generally increases with age. Comparing countries using only the number of cases can produce misleading conclusions.
There is another complication: much of the regional evidence comes from estimates rather than complete, continuously updated national cancer registries.
The International Agency for Research on Cancer (IARC) produces GLOBOCAN estimates using available cancer registry data, mortality records and statistical modelling.
These estimates are valuable, particularly where national information is incomplete. But they should not be mistaken for a complete count of every person diagnosed or every death recorded.
That distinction is especially important in the Caribbean, where cancer surveillance capacity differs considerably between countries.
Breast Cancer in the Caribbean: What the Numbers Reveal
A published analysis of GLOBOCAN 2022 breast cancer estimates reported approximately 14,862 new breast cancer cases and 5,953 breast cancer deaths across the Caribbean in 2022.
The estimated age-standardised incidence rate was 49.6 per 100,000, while the mortality rate was 18.2 per 100,000.
These figures reflect the Caribbean grouping used in that analysis, rather than every country that might be considered Caribbean in a broader cultural or political sense.
The numbers are significant, but the relationship between diagnoses and deaths deserves particular attention.
A useful population-level indicator is the mortality-to-incidence ratio, which compares deaths recorded in a period with new cases estimated for that period.
For the Caribbean, that ratio was approximately 0.40 in the analysis, compared with approximately 0.16 in Northern America.
That difference raises serious questions about breast cancer outcomes and access to effective care.
However, it is essential to understand what the ratio does not mean.
It does not mean that 40% of Caribbean women diagnosed with breast cancer will die from it. The people who died in 2022 were not necessarily the same people diagnosed that year. A mortality-to-incidence ratio is not an individual survival probability.
What it can do is highlight broad differences that warrant further investigation. And in our region, those differences cannot be ignored.
Trinidad and Tobago: A Closer Look
For those of us in Trinidad and Tobago, the national figures make the conversation particularly relevant.
According to the International Agency for Research on Cancer's GLOBOCAN 2024 country fact sheet, breast cancer was the most frequently diagnosed cancer among women in Trinidad and Tobago.
The estimates identified 654 new breast cancer cases and 284 deaths attributed to the disease in 2024. Breast cancer accounted for approximately 31.4% of all newly diagnosed cancers among women.
That is almost one in every three female cancer diagnoses.
The Ministry of Health's Cancer Report covering 2003–2020 also identifies breast cancer as the most common cancer among women during that period.
But the research goes beyond the number of diagnoses.
A study examining 2,614 breast cancer cases recorded between 1995 and 2005, with follow-up through 2009, found that only 45% were diagnosed at a localised stage. Advanced-stage disease and hormone receptor-negative cancers were associated with poorer survival.
The researchers also raised concerns about the relatively limited use of combined treatment approaches.
These findings were published in Breast Cancer Clinical Characteristics and Outcomes in Trinidad and Tobago.
The study is important, but it is historical. It cannot tell us precisely what proportion of patients are diagnosed early in 2026.
We should not use older findings to imply that nothing has improved. Equally, we should not assume that improvements have occurred without current evidence demonstrating them.
What the study does establish is that late diagnosis and treatment patterns have been documented concerns in Trinidad and Tobago, and those concerns deserve continued attention.
What About Jamaica, Barbados and the Wider Region?
One of the most important findings from Caribbean breast cancer research is that the region cannot be treated as a single, uniform population.
A 2021 review titled Breast Cancer in the Caribbean examined 117 research papers covering incidence, mortality, genetics, diagnosis, treatment and cancer control.
The researchers identified considerable differences between Caribbean countries.
Some have more established cancer registries and treatment systems. Others face significant resource limitations, including difficulties with early diagnosis and access to specialised care.
The review also found that research across the Caribbean remains limited and inconsistent, making it difficult to compare outcomes reliably.
Barbados, Jamaica, Trinidad and Tobago, Haiti, Cuba and the smaller Eastern Caribbean islands operate within different healthcare structures. Their populations, economies, medical resources and cancer reporting systems also differ.
For example, a woman in a small island state may need to travel overseas for a specialised procedure or treatment that is unavailable locally. In a larger country, the service may exist nationally but remain difficult to reach for someone living far from the relevant hospital. In another setting, treatment may be subsidised, but diagnostic delays, medicine availability or transportation expenses can still create barriers.
These examples illustrate different access challenges; they should not be interpreted as claims that every Caribbean country experiences the same problems.
The more recent figures help illustrate the scale of the problem in individual countries.
According to the International Agency for Research on Cancer's GLOBOCAN 2024 estimates for Jamaica, the country recorded approximately 1,310 new breast cancer cases and 695 deaths attributed to the disease. Breast cancer accounted for 33.3% of all new cancer diagnoses among women.
In Barbados, the estimates identified 153 new breast cancer cases and 74 deaths, with breast cancer accounting for 30.2% of new female cancer diagnoses.
Guyana recorded an estimated 215 new cases and 80 deaths, with breast cancer representing 28.1% of new cancer diagnoses among women.
Although the number of cases differs considerably, reflecting differences in population size and other factors, breast cancer was the most frequently diagnosed cancer among women in all three countries.
These are population-level estimates, not complete national case counts. They also cannot tell us, on their own, how many patients were diagnosed at an early stage, how quickly they received treatment or what their individual survival prospects were.
The country figures are from 2024, while the earlier regional comparison in this article uses 2022 estimates. They provide more recent national context and should not be added to the older regional totals.
The lesson from the research is that improving breast cancer outcomes requires understanding the specific circumstances of each country.
Working together across the Caribbean can strengthen breast cancer care, but each country must also address the particular challenges faced by its own population.
Why Early Diagnosis Matters So Much
Breast cancer is not a single disease.
Different cancers grow at different rates, respond differently to treatment and have different biological characteristics. Nevertheless, the stage at which cancer is diagnosed is one of the most important factors influencing treatment options and prognosis.
When breast cancer is detected before it has spread extensively, treatment may be less complex and the chances of successful management are generally better.
A systematic review and meta-analysis of breast cancer stage and survival in Latin America and the Caribbean examined evidence from multiple countries, including several Caribbean territories.
The review documented substantial variation in stage at diagnosis and survival, while also highlighting weaknesses in the available evidence.
Importantly, the Caribbean studies were not equally distributed across countries. Some territories had limited patient samples, while others lacked sufficient survival information.
That means we must be cautious about drawing conclusions for the entire region from a handful of studies.
Still, the wider evidence supports a critical public health principle: diagnosing breast cancer earlier and ensuring timely access to effective treatment can save lives.
And those are two separate responsibilities.
Early diagnosis without accessible treatment is not enough. Neither is investing in treatment facilities while allowing people to experience prolonged delays before receiving a diagnosis.
Both parts of the system must work.
Awareness Is Important. Access Is Just as Important.
We frequently encourage women to get screened, recognise warning signs and seek medical advice.
Those are valuable messages. But they can become frustrating, even unfair, when we overlook the circumstances in which people are expected to act on them.
Consider a woman who discovers a lump. She may need to arrange time away from work, organise childcare or find transportation to a health facility. She may have to wait for an appointment, undergo imaging and then wait again for a biopsy. If cancer is diagnosed, she may need surgery, chemotherapy, radiotherapy, hormone therapy or some combination of treatments.
Each stage can bring new financial, emotional and logistical demands. For someone with a reliable income, transportation, paid leave and family support, navigating these demands may be difficult but manageable.For someone living from pay cheque to pay cheque, supporting dependants or working without paid sick leave, the same journey can be considerably more challenging.
Even where medical treatment is provided without direct charges, patients may still face costs related to transport, meals, childcare, lost income and other necessities.
The Pan American Health Organization identifies effective early detection and access to appropriate treatment as continuing challenges in resource-limited settings.
This is why public health campaigns must do more than tell women what they should do. They must also help ensure that women can actually do it.
A screening reminder is useful. An accessible appointment is better.
What makes the difference is ensuring that people receive an accurate diagnosis without unnecessary delays and can access the treatment they need.
Are Caribbean Women Diagnosed at Younger Ages?
According to the Pan American Health Organization, approximately 32% of new breast cancer cases in Latin America and the Caribbean occur among women younger than 50, compared with 19% in North America.
These figures describe Latin America and the Caribbean together, not the Caribbean alone. They also represent the proportion of diagnoses occurring in younger women, rather than the probability that an individual woman will develop breast cancer.
Differences in population age structures, screening practices and underlying cancer rates can all influence the proportion of cases diagnosed before age 50.
Breast cancer is more common with increasing age, but it is not exclusive to older women.
A woman in her twenties, thirties or forties should not have a persistent breast lump dismissed solely because she is considered too young for cancer. Likewise, breast awareness should not begin only when someone becomes eligible for routine mammogram screening.
Understanding what is normal for your body and seeking assessment when something changes remain important throughout adulthood.
Ethnicity, Ancestry and Breast Cancer: What Does the Research Say?
This is one of the more sensitive areas of Caribbean breast cancer research, particularly in countries with ethnically diverse populations.
Trinidad and Tobago provides an important example.
A study examining 3,767 breast cancer cases recorded between 1995 and 2007 investigated associations between ancestry, geographical location, incidence, mortality and survival.
The researchers reported higher age-standardised breast cancer incidence and mortality rates among women classified as being of African ancestry than among women classified as being of East Indian or mixed ancestry. They also observed differences in treatment receipt and survival.
These findings deserve attention. But they should not be reduced to simplistic statements suggesting that one ethnic group is inherently destined to experience worse outcomes.
Cancer disparities can reflect multiple interacting influences, including tumour biology, inherited risk, socioeconomic circumstances, screening access, diagnostic delays, treatment availability and other factors.
Furthermore, the findings came from cases diagnosed decades ago. They do not establish the present-day risk or prognosis of every Afro-Trinidadian, Indo-Trinidadian or mixed-ancestry woman.
Another systematic review of social determinants of breast cancer in the Caribbean found that evidence on ethnicity and outcomes was limited and sometimes inconsistent.
For example, that review identified some historical findings suggesting higher breast cancer mortality among women of Asian-Indian ancestry in particular analyses of Trinidad and Guyana. That may appear to conflict with the Trinidad and Tobago study described above. But the studies did not necessarily use the same populations, periods, methods or statistical measures. Their results should not be treated as directly interchangeable.
We need more recent, high-quality studies that investigate disparities without assuming that ethnicity alone explains them.
We also need to consider what happens within ethnic communities.
Income, geography, education, employment, disability, family responsibilities and access to healthcare may vary considerably among people who share the same ancestry. Ethnicity can be relevant to research without being a complete explanation for an individual's health outcome. And no woman should interpret population statistics as a personal prediction of whether she will develop breast cancer or survive it.
The Problem of Incomplete Cancer Data
There is something else the research reveals, and it may be one of the most important findings of all.
We still do not know enough.
The 2021 Caribbean breast cancer review identified major gaps in the quantity, quality and consistency of regional research.
Similarly, the systematic review of social determinants found that many potentially important relationships between social circumstances and breast cancer outcomes had not been adequately investigated.
Another area deserving attention is male breast cancer. Although men can develop the disease, Caribbean-specific research on their incidence, treatment experiences and survival outcomes is limited. Without more comprehensive sex-disaggregated data, it is difficult to establish a clear regional picture of how breast cancer affects men. Their experiences deserve to be included in future research and cancer surveillance.
Why does this matter?
Because healthcare planning depends on information.
If a country does not have reliable data on how many people develop breast cancer, where they live, the stage at diagnosis, the treatment they receive and their outcomes, it becomes more difficult to identify where improvements are most urgently needed.
Cancer registries can help answer questions such as:
Are more people being diagnosed at an early stage?
Are some communities experiencing longer delays before treatment?
Are recommended therapies consistently available?
Are survival outcomes improving over time?
Are certain populations being underserved?
Without reliable answers, public health decisions may be guided by incomplete pictures of the problem.
That does not mean healthcare professionals and policymakers are doing nothing. It means the systems used to measure progress need sustained investment too.
A cancer registry may not attract the same public attention as a new treatment centre or an awareness campaign. But it is essential to understanding whether those investments are making a difference.
What Would Better Breast Cancer Care Look Like in the Caribbean?
The World Health Organization's Global Breast Cancer Initiative focuses on improving outcomes through health promotion for early detection, timely diagnosis and comprehensive breast cancer management.
Its framework recognises that reducing deaths requires coordinated healthcare systems, not isolated interventions.
For Caribbean countries, that means looking at the entire patient journey.
A person should know which breast changes require medical attention and where to seek help. Healthcare professionals should have appropriate pathways for investigating suspicious symptoms. Diagnostic imaging and biopsy services should be available within reasonable timeframes. Once cancer is confirmed, patients should be able to access the treatments recommended for their particular diagnosis.
And care should not end when active treatment finishes.
People may need rehabilitation, management of treatment side effects, emotional support, follow-up appointments and assistance returning to work or navigating financial difficulties.
For smaller Caribbean territories, regional partnerships may also help expand access to specialised services that are difficult to maintain independently.
But better care requires more than infrastructure. It also requires communication.
Patients deserve to understand their diagnosis, treatment options, expected side effects and follow-up plans. They deserve explanations in language they can understand. They deserve to ask questions without being dismissed. And they deserve care that recognises their circumstances rather than treating every patient as though she has the same resources, responsibilities and support system.
What Can We Do as Individuals and Communities?
We cannot personally solve every weakness in a healthcare system, but we can contribute to a culture where breast health is taken seriously and people are supported rather than blamed.
We can encourage relatives and friends to seek medical assessment when they notice unusual changes. We can share accurate information rather than frightening rumours or unverified medical claims. We can support someone attending appointments, help with transportation or childcare, or simply listen when they need to talk. Employers can examine whether workplace policies make it possible for employees to attend medical appointments and receive treatment without unnecessary hardship. Community organisations can help connect people with reliable services and information. And as citizens, we can ask questions about screening access, diagnostic delays, cancer registries and the availability of treatment.
These are legitimate public health concerns.
Because improving breast cancer outcomes should not depend entirely on how persistent, financially secure or well-connected an individual patient happens to be.
Beyond the Pink Ribbons
Breast cancer awareness has helped bring an important health issue into public conversation, but the research reminds us that knowing about a disease and being able to obtain timely, effective care are not the same thing.
Across the Caribbean, women face different circumstances, different healthcare systems and different obstacles.
Some are diagnosed early and receive appropriate treatment. Others encounter delays, financial pressures or gaps in access that can make an already frightening experience even more difficult.
The evidence also tells us that our region needs stronger cancer surveillance, more consistent research and closer examination of inequalities.
We should celebrate progress where it exists. We should acknowledge the healthcare professionals, researchers, advocates and organisations working to improve breast cancer care.
But we should also be willing to ask difficult questions.
Who is being diagnosed too late?
Who is struggling to access treatment?
Whose experiences are missing from the research?
What would it take to ensure that a woman's chances of receiving appropriate care are not determined by where she lives or what she can afford?
Because breast cancer awareness should lead somewhere.
Towards better information. Towards earlier diagnosis. Towards accessible treatment. Towards stronger support for patients and families.
And ultimately, towards fewer lives lost.
The Caribbean deserves more than awareness. We deserve healthcare systems capable of turning awareness into action.
Whisper to Your Heart
Behind every breast cancer statistic is a person with fears, hopes and a life that matters. Whether you are facing a diagnosis or supporting someone who is, remember that you deserve compassion, honest answers and care that sees you as more than a patient. You should never have to fight to be heard.
— Nadia Renata | Audacious Evolution
Affirmation
I deserve accurate information, compassionate care and meaningful support. My concerns deserve to be heard, my questions deserve answers, and my wellbeing matters. — Nadia Renata | Audacious Evolution
Where to Find Breast Cancer Information and Support in Trinidad and Tobago
If you have concerns about breast health, a suspicious lump or another unusual change, seek assessment from a healthcare professional.
The Trinidad and Tobago Cancer Society provides cancer education, screening services and support information for people affected by cancer and their families.
Trinidad and Tobago Cancer Society
69 Dundonald Street, Port of Spain
Telephone: (868) 226-1221
Email: projects@cancer.tt
Website: www.cancertt.com
Contact the Society directly to enquire about current screening services, costs, eligibility and available support.
For readers elsewhere in the Caribbean, your national Ministry of Health, public healthcare provider or recognised cancer organisation can help identify locally available services.
If you have noticed a new or concerning breast change, do not wait for a routine screening campaign before seeking medical advice.
References and Further Reading
International Agency for Research on Cancer — Global Cancer Observatory
Global Burden and Trends of Breast Cancer — GLOBOCAN 2022 Estimates
Trinidad and Tobago Ministry of Health — Cancer Report 2003–2020
Breast Cancer Clinical Characteristics and Outcomes in Trinidad and Tobago
Associations Among Ancestry, Geography and Breast Cancer in Trinidad and Tobago
Social Determinants of Breast Cancer in the Caribbean: A Systematic Review
Stage at Diagnosis and Stage-Specific Survival in Latin America and the Caribbean
Enjoyed reading this and want more from Audacious Evolution?
Discover reflections, insights and inspiration across Body, Mind, Spirit and Community.
Comments